Malaysia's strategic location in Southeast Asia makes it a key trade and commerce hub, including for the pharmaceutical industry. The sector has seen significant growth due to technological advancements, rising healthcare demand, and supportive government policies.
Investment Opportunities in Pharmaceutical
Investment opportunities in the Malaysian pharmaceutical industry are abundant, with opportunities for manufacturing, research and development, and distribution. The country's well-developed infrastructure makes it an attractive location for foreign investors.
Biopharmaceuticals (Biosimilars/Biologics)
The expansion of biosimilars is poised to significantly impact the biopharmaceutical industry. Similar to the way generics have transformed the Malaysian pharmaceutical sector, biosimilars are expected to bring substantial changes.
Biopharmaceuticals are pricier than traditional meds, but Malaysia offers a cost-effective option for investors with its supportive ecosystem. As first-gen biopharmaceuticals mature, major companies are eyeing Malaysia for production relocation due to its strong value proposition.
In Malaysia, both local and international players are already involved in activities such as producing biopharmaceutical APIs and providing FDA/EMEA cGMP compliant services, focusing on monoclonal antibodies and recombinant proteins.
Additionally, specialised research, development, and commercialisation of biopharmaceutical products are ongoing. The government is encouraging potential investors to advance up the value chain, making Malaysia a strategic location for biopharmaceutical ventures.
Contract Manufacturing
The current trend among major global drug companies is to outsource their manufacturing operations. This allows them to focus on the time-consuming and costly 'gene hunting' methods of R&D for new drug discovery.
This presents an opportunity for the pharmaceutical industry in Malaysia to step in. By manufacturing generic and patented products for these companies on a contract basis, local companies can provide valuable services.
Several local manufacturers are eager to offer contract manufacturing services to interested parties.
Industrial Specialised Parks and Facilities
To accommodate the growing demand for pharmaceutical manufacturing and research, Malaysia has developed several industrial specialised parks. These facilities offer state-of-the-art infrastructure, such as clean rooms, high-speed production equipment, and advanced laboratories.
Bio-XCell Malaysia
Bio-XCell is a premier biotechnology park in Nusajaya, Johor, Malaysia, focused on healthcare and industrial biotech. Situated on 160 acres near the Singapore border, it offers excellent global connectivity, with access to 5 seaports and 2 international airports within 59 km.
Bio-XCell offers a conducive environment for developing and manufacturing biologics, pharmaceuticals, bio-based/green chemicals, and other solutions aimed at healing, fuelling, and greening the world.
As a managed park, Bio-XCell provides clients and investors with valuable benefits including comprehensive infrastructure, high-speed internet access, park maintenance, security, and core facilities to support the ecosystem.
Browse more: Industrial Properties in Johor.
Enstek
Situated in the township of Bandar Enstek, techpark@enstek is conveniently located just 10 minutes from Kuala Lumpur International Airport (KLIA) and 38 minutes from downtown Kuala Lumpur via the Express Rail Link (ERL).
Bandar Enstek comprises residential zones, a technology park, a commercial hub, and institutional zones. Techpark@Enstek aspires to be a world-class hub for high-tech, eco-conscious industries like biotechnology, green technology, and ICT.
The area is equipped with the necessary infrastructure and amenities to support these sectors.
Browse more: Industrial Properties in Negeri Sembilan.
Legal Framework of Pharmaceutical Industry
Malaysia's pharmaceutical industry is regulated by many laws. The National Pharmaceutical Regulatory Agency (NPRA) enforces these standards, inspecting facilities, assessing new products, and monitoring safety.
Non-compliance can lead to licence suspension or cancellation, with specific licences issued by the Drug Control Authority (DCA) required for various activities. There are three key licences:
- Manufacturer’s Licence for manufacturers.
- Import Licence for importers.
- Wholesale Dealer’s Licence for wholesalers and distributors.
These must be periodically renewed to meet regulatory standards. Applications are submitted via the NPRA online portal and assessed by the DCA, possibly involving facility inspections and product testing. Approved applications result in the issuance of the licence.
Pharmaceutical companies in Malaysia must adhere to Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) guidelines, overseen by the Ministry of Health (MOH), NPRA, and DCA. Non-compliance can result in fines, licence suspension, or criminal charges.
This regulatory framework ensures high standards of safety and efficacy in pharmaceutical products, fostering consumer confidence and industry growth.
Business Framework
Registering a company in Malaysia requires oversight by the Companies Commission of Malaysia (CCM). Pharmaceutical companies need to submit documents and fees, and comply with the MOH, NPRA, and DCA regulations.
As of December 2019, there are 263 licensed manufacturers including major firms like Duopharma Berhad and Hovid Berhad, while multinationals like Pfizer mainly serve as drug importers.
Read more: Business Premise Licence for Factory or Warehouse.
Intellectual Property Protection
Pharmaceutical companies must protect their intellectual property to maintain a competitive edge. Malaysia offers robust IP protections through patents, trademarks, and copyrights and is part of international agreements like WIPO, the Paris Convention, and TRIPS.
However, Malaysia's pharmaceutical market is highly competitive, with many multinational and local companies, presenting challenges. Understanding the business environment is essential for successful market entry or expansion.
Pharmaceutical Industry and Industrial Malaysia
Malaysia's pharmaceutical industry is set for a bright future, driven by strategic government initiatives, robust infrastructure, and a favourable regulatory environment. Malaysia is poised to become a regional leader in biopharmaceutical manufacturing and research.
Join the ranks of leading companies that have chosen Industrial Malaysia as their real estate partner. Our commitment to providing exceptional service and high-quality facilities makes us the preferred choice for businesses looking to thrive in Malaysia's dynamic industrial landscape.
WhatsApp us today and make a significant impact in the pharmaceutical industry.
